Clonal dynamics following p53 loss of heterozygosity in Kras-driven cancers
Using mosaic analysis with double markers to label genetically-distinct clones in established tumors, the authors studied the effects of p53 loss in lung and pancreatic cancers. They find that loss of p53 enhances progression in both models but only influences initiation in the pancreas.
Guardado en:
Autores principales: | Mandar Deepak Muzumdar, Kimberly Judith Dorans, Katherine Minjee Chung, Rebecca Robbins, Tuomas Tammela, Vasilena Gocheva, Carman Man-Chung Li, Tyler Jacks |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bdfbd4f291674e74b291c197db3849ac |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Survival of pancreatic cancer cells lacking KRAS function
por: Mandar Deepak Muzumdar, et al.
Publicado: (2017) -
Suppression of HSF1 activity by wildtype p53 creates a driving force for p53 loss-of-heterozygosity
por: Tamara Isermann, et al.
Publicado: (2021) -
NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation
por: Jean-Philippe Brosseau, et al.
Publicado: (2018) -
Mutant p53 drives clonal hematopoiesis through modulating epigenetic pathway
por: Sisi Chen, et al.
Publicado: (2019) -
Gene Therapy Targeting p53 and KRAS for Colorectal Cancer Treatment: A Myth or the Way Forward?
por: Hidayati Husainy Hasbullah, et al.
Publicado: (2021)